Nitric oxide and septic shock

General Pharmacology

Volumn 29, Issue 2, 1997, Pages 159-166

  Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Endotoxin; Gram positive shock; Inducible nitric oxide synthase; Multiple organ failure

Indexed keywords

5 (2,2 DICYANOVINYL) 2 NITROPHENOL; AMINOGUANIDINE; BRAIN ENZYME; CALPASTATIN; COUMARIN DERIVATIVE; CYTOKINE; DEXAMETHASONE; ENDOTOXIN; ERBSTATIN; GENISTEIN; GLIBENCLAMIDE; INDAZOLE DERIVATIVE; ISOENZYME; KETAMINE; MONOCLONAL ANTIBODY; N ACETYLSEROTONIN; N(G) METHYLARGININE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMATE; SCAVENGER; SPERMINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TYRPHOSTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL MODEL; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; DRUG MECHANISM; ENDOTHELIUM; ENZYME INDUCTION; ENZYME INHIBITION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODYNAMICS; HOST RESISTANCE; HUMAN; HYPOTENSION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SHOCK, SEPTIC;

EID: 0030843135     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00410-7     Document Type: Review

References (55)

1. Baue A. E. (1993) The multiple organ or systems failure syndrome. In Pathophysiology of Shock, Sepsis and Organ Failure. (Edited by Schlag G. and Redl H.) pp. 1004-1018. Springer, Berlin.
2. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
3. Bone R. C. (1994) Gram-positive organisms and sepsis. Arch. Intern. Med. 154, 26-34.
4. Billiar T. R., Curran R. D., Harbrecht B. G., Stuehr D. J., Demetris A. J. and Simmons R. L. (1990) Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J. Leukoc. Biol. 48, 565-569.
5. Conner J. R., Manning P. T., Settle S. L., Moore W. M., Jerome G. M., Webber R. K., Tjoeng F. S. and Currie M. G. (1995) Suppression of adjuvant-induced arthritis by selective inhibition of inducible-nitric oxide synthase. Eur. J. Pharmacol. 273, 15-24.
6. Corbett J. A., Tilton R. G., Chang, K., Hasan K. S., Ido Y., Wang J. L., Sweetland M. A., Lancaster J. R., Williamson J. R. and McDaniel M. L. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41, 552-558.
7. Curran R. D., Ferrari F. K., Kispert K. H., Stadler J., Stuehr D. J., Simmons R. L. and Billiar T. R. (1991) Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5, 2085-2095.
8. DeKimpe S. J., Kengatharan M., Thiemermann C. and Vane J. R. (1995) The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92, 10359-10363.
9. Dinerman J. L., Lowenstein C. J. and Snyder S. H. (1993) Molecular mechanism of nitric oxide regulation: potential relevance to cardiovascular disease. Circ. Res. 73, 217-222.
10. Evans T., Carpenter A., Kinderman H. and Cohen J. (1993) Evidence of increased nitric oxide production in patients with sepsis syndrome. Circ. Shock 41, 77-81.
11. Garvey P. E., Oplinger J. A., Tanoury G. J., Sherman P. A., Fowler M., Marshall S., Marmon M. F., Paith J. E. and Furfine E. S. (1994) Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J. Biol. Chem. 269, 26669-26676.
12. Julou-Schaeffer G., Gray G. A., Fleming I., Schott C., Parratt J. R. and Stoclet J. C. (1990) Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am. J. Physiol. 259, H1038-H1043.
13. G-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172, 1132-1138.
14. G-methyl-L-arginine inhibits tumour necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87, 3629-3632.
15. Klemm P., Hecker M., Stockhausen H., Wu C. C. and Thiemermann C. (1995a) Inhibition by N-acetyl-serotonin of nitric oxide synthase expression in cultured cells and in anaesthetised rats. Br. J. Pharmacol. 115, 1175-1181.
16. Klemm P., Thiemermann C., Winklmaier G., Martorana P. A. and Henning R. (1995b) Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxic shock. Br. J. Pharmacol. 114, 363-368.
17. Kumar A. and Parvillo J. E. (1995) Influence of nitric oxide on cardiac systolic and distolic function. In Role of nitric oxide in sepsis and ARDS. (Edited by Fink M. P. and Payen D.) 100-113, Springer, New York.
18. Lefer A. M. (1995) Cellular actions of nitric oxide in the circulatory system. In Role of Nitric Oxide in Sepsis and ARDS (Edited by Fink M. P. and Payen D.) 114-124, Springer, New York.
19. MacMicking J. D., Nathan C., Hom G. et al. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 82, 641-650.
20. Meyer J., Traber L. D., Nelson S., Lentz C. W., Nakazawa H., Herndon D. N., Noda H. and Traber D. L. (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J. Appl. Physiol. 73, 324-328.
21. Meyer J., Lentz C. W., Stothert J. C., Traber L. D., Herndon D. N. and Traber D. L. (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit. Care Med. 22, 306-312.
22. Misko T. P., Moore W. M., Kasten T. P., Nickols D. A., Corbett J.A., Tilton R. G., McDaniel M. L., Williamson J. R. and Currie M. G. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233, 119-125.
23. Moncada S. and Higgs A. (1993) The L-arginine-nitric oxide pathway. N. Eng. J. Med. 329, 2202-2212.
24. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
25. G-nitro arginine, a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vivo. Br. J. Pharmacol. 99, 408-412.
26. Morris S. M. and Billiar T. R. (1994). New insights into the regulation of inducible nitric oxide synthase. Am. J. Physiol. 266, E829-E839.
27. Nathan C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
28. Nathanson C., Hoffmann W. D., Suffredini E. F., Eichacker P. Q. and Danner R. L. (1994) Selected treatment strategies for septic shock based on proposed mechanism of pathogenesis. Ann. Intern. Med. 120, 771-783.
29. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osheror N. and Levitzki A. (1994) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibition. Science 264, 1319-1322.
30. Parillo J. E. (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann. Intern. Med. 113, 227-242.
31. Petros A., Lamb G., Leone A., Moncada S., Bennett D. and Vallance P. (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28, 34-39.
32. Preiser J. C. and Vincent J. L. (1996) Nitric oxide involvement in septic shock: do human beings behave like rodents? In 1996 Yearbook of Intensive Care and Emergency Medicine. (Edited by Vincent J. L.) pp. 358-365. Springer, Berlin.
33. Rees D. D., Cellek S., Palmer R. M. J. and Moncada S. (1990) Dexamethasone prevents the induction of nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock. Biochem. Biophys. Res. Commun. 173, 541-547.
34. Ruetten H., Southan G. J., Abate A. and Thiemermann C. (1996) Attenuation of the multiple organ dysfunction caused by endotoxin by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol 118, 261-270.
35. Schraufstatter I., Hinshaw D., Hyslop P., Spragg R. and Cochrane C. (1986) Oxidant injury of cells. DNA strand breaks activate polyadenosine diphosphate ribose polymerase and lend to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77, 1312-1319.
36. Southan G. J. and Szabo C. (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51, 383-394.
37. Southan G., Szabo C. and Thiemermann C. (1995a) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol. 114, 510-516.
38. Southan G. J., Szabo C., O'Conner M. P., Salzman A. C. and Thiemermann C. (1995b) Amidines are potent inhibitors of constitutive and inducible nitric oxide synthases: Preferential inhibition of the inducible isoform. Eur. J. Pharmacol.
39. Stevens D. L., Tanner M. H. and Winship J. (1989) Severe Group A streptococcal infections associated with a toxic shock syndrome and scarlet fever toxin. N. Engl. J. Med. 321, 1-7.
40. Szabo C. and Thiemermann C. (1994) Role of nitric oxide in haemorrhage, traumatic and anaphylactic shock, and thermal injury. Shock 2, 145-155.
41. Szabo C. and Thiemermann C. (1995) Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv. Pharmacol. 34, 113-154.
42. Szabo C., Mitchell J. A., Thiemermann C. and Vane J. R. (1993). Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108, 786-792.
43. Szabo C., Thiemermann C., Wu C. C., Perretti M. and Vane J. R. (1994a) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids. Proc. Natl. Acad. Sci. USA 91, 271-275.
44. Szabo C., Southan G. and Thiemermann C. (1994b) Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91, 12472-12476.
45. Thiemermann C. (1994) The role of L-arginine:nitric oxide pathway in citculatory shock. Adv. Pharmacol. 28, 45-79.
46. Thiemermann C. and Vane J. R. (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat. Eur. J. Pharmacol. 182, 591-595.
47. Thiemermann C., Szabo C., Mitchell J. A. and Vane J. R. (1993) Vascular hyporeactivity to vasoconstrictor agents and haemodynamic decompensation in haemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. USA 90, 267-271.
48. Thiemermann C., Ruetten H., Wu C. C. and Vane J. R. (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol. 116, 2845-2851.
49. Wei X., Charles I. G., Smith A. et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
50. Wright C. E., Rees D. D. and Moncada S. (1992) Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc. Res. 26, 48-57.
51. Wolff D. J. and Lubeskie A. (1995) Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316, 290-301.
52. Wu C. C., Croxtall J. D., Perretti M., Bryant C., Thiemermann C., Flower R. J. and Vane J. R. (1995a) Lipocortin-1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc. Natl. Acad. Sci. USA 92, 3473-3477.
53. Wu C. C., Chen S. J., Szabo C., Thiemermann C. and Vane J. R. (1995b) Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114, 1666-1672.
54. Wu C. C., Ruetten H. and Thiemermann C. (1996) Comparison of the effects of aminoguanidine and NG-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol. 300, 99-104.
55. Zingarelli B., O'Conner M., Wong H., Salzman A. L. and Szabo C. (in press). Peroxynitrite-mediated DNA breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol.